US Patent Issued to EDITAS MEDICINE on Feb. 10 for "CRISPR/Cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,912, issued on Feb. 10, was assigned to EDITAS MEDICINE INC. (Cambridge, Mass.).

"CRISPR/Cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa" was invented by Morgan L. Maeder (Jamaica Plain, Mass.) and David A. Bumcrot (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "CRISPR/Cas-related compositions and methods for treatment of Usher Syndrome and/or Retinitis Pigmentosa are disclosed herein."

The patent was filed on June 7, 2021, under Application No. 17/341,244.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=...